NCT00072865View on ClinicalTrials.gov

Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

September 30, 2005

Conditions
Breast CancerNeoplasm Metastasis
Interventions
DRUG

Pemetrexed

DRUG

Carboplatin

Trial Locations (2)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Moscow

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Saint Petersburg

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00072865 - Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter